Pack Cell with Complete Screening Service at Chughtai Lab

Pack Cell with Complete Screening (One Bag) at Chughtai Lab

Packed Red Blood Cells (PRBCs), commonly referred to as pack cells, represent a critical component of modern transfusion medicine. This specialized blood product is prepared by centrifuging a unit of whole blood to separate and remove the majority of the liquid plasma, leaving behind a highly concentrated suspension of red blood cells. The primary clinical objective of administering packed red blood cells is to rapidly restore and maintain adequate tissue oxygenation in patients suffering from severe anemia, acute blood loss, or bone marrow failure, without causing cardiovascular volume overload. At Chughtai Lab, one of Pakistan’s premier diagnostic and healthcare networks, the Pack Cell with Complete Screening (One Bag) service ensures that patients receive a highly purified, immunologically compatible, and thoroughly screened blood product that adheres to international safety standards.

The therapeutic efficacy of a packed cell transfusion depends heavily on the safety and compatibility of the donor unit. The complete screening process is a rigorous, multi-tiered laboratory evaluation designed to eliminate the risk of Transfusion-Transmitted Infections (TTIs) and prevent immunological complications. This comprehensive panel includes high-sensitivity testing for major bloodborne pathogens, detailed ABO and Rh blood grouping, and precise crossmatching. By utilizing state-of-the-art chemiluminescence immunoassays (CLIA) and advanced molecular techniques, Chughtai Lab minimizes the window period risk of infectious agents, providing a safe and life-saving biological product for patients undergoing major surgeries, cancer therapies, or emergency trauma care.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure the safety, accuracy, and efficiency of the blood crossmatching and transfusion process. Patients and their families should observe the following guidelines:

• Physician Requisition: A valid, signed prescription or blood transfusion requisition form from a registered medical practitioner is mandatory. This form must specify the patient’s clinical indication, required number of bags, and any history of previous transfusions or reactions.
• Identification and Documentation: The patient must present valid identification (such as a CNIC or hospital registration card) to prevent clerical errors, which are the leading cause of acute hemolytic transfusion reactions globally.
• Medical History Disclosure: Inform the laboratory staff and attending physicians of any history of pregnancies, prior blood transfusions, known alloantibodies, or drug allergies.
• Dietary Restrictions: No fasting is required for the recipient’s blood sample collection. The patient may eat and drink normally unless otherwise instructed by their primary physician for concurrent tests.
• Medication Management: Continue taking regular medications unless specifically advised to stop by the prescribing doctor.

During the Procedure

The procedure involves two distinct phases: the collection of the recipient’s blood sample for compatibility testing, and the preparation and screening of the donor blood bag at the Chughtai Lab blood bank.

• Recipient Sample Collection: A certified phlebotomist will perform a standard venipuncture, usually drawing blood from a vein in the antecubital fossa. The area is thoroughly sanitized with an antiseptic solution, and a small sample is collected into an EDTA (purple top) tube and a plain (red top) tube. This process takes less than five minutes and involves minimal discomfort.
• Donor Unit Selection and Processing: A healthy, pre-screened donor unit of the appropriate blood group is selected from the inventory. The whole blood is centrifuged under controlled temperature conditions to separate the red blood cells from the plasma and platelets.
• Infectious Disease Screening: The donor bag undergoes mandatory, high-sensitivity screening for major infectious markers, including Hepatitis B Surface Antigen (HBsAg), Hepatitis C Virus (HCV) antibodies, Human Immunodeficiency Virus (HIV-1/2) antibodies and antigens, Syphilis (Treponema pallidum), and Malaria parasites.
• Compatibility Testing (Crossmatching): The laboratory technologist performs a major crossmatch by mixing the recipient’s serum with the donor’s red blood cells. This mixture is incubated and observed for agglutination (clumping) or hemolysis, which would indicate incompatibility. Only completely compatible units are approved for release.

When is a Pack Cell with Complete Screening (One Bag) Performed?

Severe Acute Hemorrhage

Acute blood loss resulting from major trauma, vehicular accidents, obstetric emergencies (such as postpartum hemorrhage), or extensive surgical procedures requires rapid intervention. When blood loss exceeds 30% of the patient’s circulating volume, hemodynamic stability is compromised, and tissue perfusion drops dangerously. Physicians request packed red blood cells to quickly restore intravascular volume and oxygen-carrying capacity, preventing hypovolemic shock and multi-organ failure.

Chronic Symptomatic Anemia

Patients suffering from chronic anemia secondary to chronic kidney disease (CKD), chronic inflammatory disorders, or severe nutritional deficiencies may experience debilitating symptoms when their hemoglobin levels fall below critical thresholds (typically less than 7 to 8 g/dL). Symptoms include severe fatigue, dyspnea on exertion, dizziness, and tachycardia. Transfusion of packed cells helps alleviate these symptoms and improves the patient’s functional quality of life.

Hemoglobinopathies and Inherited Disorders

Inherited red blood cell disorders, such as Thalassemia Major and Sickle Cell Disease, impair the body’s ability to produce functional hemoglobin. Patients with these conditions require lifelong, regular blood transfusions to suppress ineffective erythropoiesis, manage severe anemia, and prevent complications like skeletal deformities and splenomegaly. The complete screening process is vital for these patients to prevent alloimmunization and the transmission of infectious diseases over multiple transfusions.

Oncology and Hematological Malignancies

Cancers of the blood and bone marrow, such as leukemia, lymphoma, and multiple myeloma, directly suppress the production of healthy red blood cells. Furthermore, aggressive chemotherapy and radiation therapy regimens cause profound bone marrow suppression (myelosuppression). Transfusion of screened packed cells supports these patients through their treatment cycles, maintaining physiological oxygen levels and preventing life-threatening anemic complications.

Bone Marrow Failure Syndromes

Conditions such as aplastic anemia, myelodysplastic syndromes (MDS), and myelofibrosis result in a primary failure of the bone marrow to produce adequate cellular blood components. Because these patients cannot synthesize sufficient red blood cells, they rely on periodic packed cell transfusions. Rigorous screening of each bag is critical to protect these immunocompromised individuals from opportunistic infections and transfusion-related complications.

What Does a Pack Cell with Complete Screening Detect?

The screening and compatibility testing process at Chughtai Lab evaluates multiple critical parameters to ensure transfusion safety. This comprehensive testing detects and identifies:

• ABO Blood Group System: Identifies the presence of A and/or B antigens on the red blood cells to classify the blood as type A, B, AB, or O.
• Rh (D) Antigen Status: Determines whether the Rh(D) antigen is present (positive) or absent (negative) on the red cell surface.
• Hepatitis B Surface Antigen (HBsAg): Detects active Hepatitis B infection in the donor blood unit.
• Hepatitis C Virus (HCV) Antibodies: Identifies exposure to and potential chronic infection with the Hepatitis C virus.
• HIV-1 and HIV-2 Antibodies/Antigens: Screens for the presence of antibodies to HIV-1/2 and the p24 antigen to prevent transfusion-transmitted AIDS.
• Syphilis Antibodies: Detects antibodies against Treponema pallidum, the causative agent of syphilis.
• Malaria Parasites: Screens for the presence of Plasmodium falciparum and Plasmodium vivax to prevent transfusion-transmitted malaria.
• Major Crossmatch Compatibility: Detects any pre-existing antibodies in the recipient’s serum directed against the donor’s red blood cells.
• Minor Crossmatch Compatibility: Evaluates the donor’s plasma for antibodies directed against the recipient’s red blood cells.
• Unexpected Red Cell Alloantibodies: Screens the recipient’s serum for atypical antibodies resulting from previous transfusions or pregnancies.
• Direct Antiglobulin Test (DAT) Reactivity: Detects antibodies or complement proteins bound directly to the surface of red blood cells.
• Indirect Antiglobulin Test (IAT) Reactivity: Identifies unbound circulating red cell antibodies in the patient’s serum.
• Weak D (Du) Variant: Detects weak expressions of the Rh(D) antigen in donors to prevent accidental sensitization of Rh-negative recipients.
• Bacterial Contamination: Screens for potential bacterial proliferation within the blood unit, which can cause fatal septic transfusion reactions.
• Hemolysis in the Donor Bag: Identifies premature rupture of red blood cells within the bag, indicating poor storage conditions or cell damage.
• Atypical Antibodies: Detects clinically significant non-ABO antibodies (such as Kell, Duffy, Kidd, or MNS systems) that could cause delayed hemolytic reactions.
• Hematocrit (Packed Cell Volume) Levels: Evaluates the concentration of red blood cells in the prepared bag to ensure therapeutic potency.
• Leukocyte Contamination: Assesses the presence of residual white blood cells, which can cause febrile non-hemolytic transfusion reactions (FNHTR).
• Clot Formation: Detects microclots within the bag that could obstruct transfusion filters or cause microemboli.
• Storage Lesion Indicators: Identifies physical or chemical changes in the blood unit that occur during prolonged storage, ensuring only viable cells are transfused.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab understands the critical and often emergency nature of blood transfusions. For routine cases, the complete screening and crossmatching process for a single bag of packed cells is typically completed within 4 to 6 hours. In urgent or life-threatening clinical scenarios, emergency crossmatching protocols (such as immediate-spin crossmatch) can be executed rapidly, with compatible units prepared in approximately 1 to 2 hours, provided no atypical antibodies are detected.

Once the screening and compatibility testing are complete, a detailed compatibility report and transfusion certificate are generated. These documents can be accessed instantly online via the official Chughtai Lab website or through the Chughtai Healthcare mobile application. Patients and healthcare providers receive real-time SMS alerts containing direct links to download the PDF reports. Physical copies of the compatibility report, along with the crossmatched blood bag, must be collected directly from the designated Chughtai Lab blood bank branch by an authorized representative to maintain strict chain-of-custody protocols.

Pack Cell with Complete Screening Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
ABO & Rh Grouping	Consistent with recipient’s established blood type	Grouping discrepancies, weak D expression, or typing mismatches
HBsAg Screening	Non-Reactive (Negative)	Reactive (Positive) indicating active Hepatitis B infection
HCV Antibody Screening	Non-Reactive (Negative)	Reactive (Positive) indicating active or past Hepatitis C infection
HIV-1/2 Ag/Ab Screening	Non-Reactive (Negative)	Reactive (Positive) indicating potential HIV infection
Syphilis (VDRL/TPHA)	Non-Reactive (Negative)	Reactive (Positive) indicating active or latent syphilis infection
Malaria ICT/Smear	Not Detected (Negative)	Presence of Plasmodium species (Positive)
Major Crossmatch	Compatible (No agglutination or hemolysis)	Incompatible (Agglutination or hemolysis present)
Antibody Screen (IAT)	Negative (No clinically significant alloantibodies)	Positive (Presence of atypical red cell antibodies)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Pack Cell with Complete Screening?

• Experienced Healthcare Professionals: Managed by highly qualified hematologists, transfusion medicine specialists, and certified laboratory technologists.
• Patient-Focused Care: Dedicated support staff to assist patients and their families through the blood requisition and collection process.
• Quality Diagnostic Services: Strict adherence to national and international blood banking guidelines to ensure maximum safety.
• Professional Reporting: Accurate, clear, and comprehensive compatibility reports detailing all screening parameters.
• Modern Diagnostic Approach: Utilization of advanced chemiluminescence and automated gel card systems for precise crossmatching.
• Comfortable Environment: Clean, hygienic, and state-of-the-art blood collection centers and blood bank facilities.
• Convenient Location: An extensive network of branches and collection points across major cities in Pakistan, ensuring rapid accessibility.
• Commitment to Accurate Diagnosis: Rigorous internal and external quality control programs to eliminate false-negative screening results.